Incannex Healthcare Inc.
For the period ended Jun 30, 2025. Filed Sep 29, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 29, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on the signature page hereto)
POWER OF ATTORNEY
IN WITNESS WHEREOF, each person whose signature appears below constitutes and appoints Joel Latham and Joseph Swan as his true and lawful agent, proxy and attorney-in-fact, each acting alone, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to (i) act on and sign any amendments to this report, with exhibits thereto and other documents in connection therewith, (ii) act on and sign such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, and in each case file the same with the SEC, hereby approving, ratifying and confirming all that such agent, proxy and attorney-in-fact or any of his substitutes may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Position | Date |
|---|---|---|
| /s/ Joel Latham | Chief Executive Officer, President and Director | September 29, 2025 |
| Joel Latham | (principal executive officer) | |
| /s/ Joseph Swan | Chief Financial Officer | September 29, 2025 |
| Joseph Swan | (principal financial and accounting officer) | |
| /s/ Troy Valentine | Director | September 29, 2025 |
| Troy Valentine | ||
| /s/ Peter Widdows | Director | September 29, 2025 |
| Peter Widdows | ||
| /s/ George Anastassov | Director | September 29, 2025 |
| George Anastassov | ||
| /s/ Robert Clark | Director | September 29, 2025 |
| Robert Clark | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.